Dr. Pablo R. Castro, MD

Dr. Castro practices at Adventist Health Physicians Network in Lodi, California.

Dr. Castro's NPI, 1538422316, was assigned on June 18, 2012. Dr. Castro graduated from Universidad Autonoma de Nicaragua Faculty of Medicine in 1989. Dr. Castro holds Puerto Rico license 12389.

Dr. Castro's primary practice is Adventist Health Physicians Network, at 1901 W Kettleman Ln, Lodi, CA 95242 in San Joaquin County. The practice phone is (209) 334-8540.

Dr. Castro's primary practice is Adventist Health Physicians Network in Lodi, California. Dr. Castro is also affiliated with Adventist Health Lodi Memorial. The medical group on file is Adventist Health Physicians Network. Dmand AI also links Dr. Castro to 4 more home health agencies, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Castro practices, 7 sites in all. Vendor and product names are available with a free account.

General practice is Dr. Castro's primary specialty in the NPI Registry, under taxonomy code 208D00000X. Dr. Castro is board certified in family medicine by the American Board of Family Medicine. Dmand AI has Dr. Castro's licenses on file in 2 states: Puerto Rico and California.

Dmand AI lists acid reflux, acute skin infection, alcohol use disorders, aneurysm, anxiety, arthritis, atrial fibrillation and flutter and benign or precancerous skin growths among the conditions Dr. Castro treats.

CMS data shows 2,258 Medicare services from Dr. Castro across 17 procedure codes in 2024, for 343 Medicare patients. Medicare paid $179,214 for them. Every service was in an office.

CMS counts 343 Medicare patients who saw Dr. Castro in 2024. The largest group is 65 to 74, with 150 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 53% are also on Medicaid. Their average risk score is 1.23, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Castro's median patient age at 70, with 53% women.

In 2024, Dr. Castro wrote 16,557 Medicare Part D claims for 911 patients. 84% of them were for generic drugs. CMS names the drug for 15,765 of them, across 144 drugs with 11 or more claims each, at $1,993,090 in total drug cost. In 2023, CMS named 12,580 claims across 124 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Castro for performance year 2024, reported through an alternative payment model (APM). Dr. Castro accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Castro as offering telehealth. CMS counts 15 procedures of removal of skin lesions by Dr. Castro, more than 62% of the clinicians it reports for that procedure.

Dmand AI links Dr. Castro to 1 clinical trial. Conditions studied include Familial Primary Pulmonary Hypertension and Hypertension, Pulmonary.

CMS Open Payments shows 298 general payments to Dr. Castro from 29 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Novo Nordisk Inc paid the most, $2,161.

Dr. Castro graduated from Universidad Autonoma de Nicaragua Faculty of Medicine in 1989.

Dr. Castro is in network with 16 carriers, including Blue Cross Blue Shield of Michigan, United Healthcare and Elevance. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.